179 related articles for article (PubMed ID: 11480538)
1. Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells.
Furusawa S; Nakano S; Wu J; Sakaguchi S; Takayanagi M; Sasaki KI; Satoh S
J Pharm Pharmacol; 2001 Jul; 53(7):1029-39. PubMed ID: 11480538
[TBL] [Abstract][Full Text] [Related]
2. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Ling YH; Priebe W; Perez-Soler R
Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM.
Genne P; Duchamp O; Solary E; Pinard D; Belon JP; Dimanche-Boitrel MT; Chauffert B
Leukemia; 1994 Jan; 8(1):160-4. PubMed ID: 8289482
[TBL] [Abstract][Full Text] [Related]
5. Effects of cis-unsaturated fatty acids on doxorubicin sensitivity in P388/DOX resistant and P388 parental cell lines.
Liu QY; Tan BK
Life Sci; 2000; 67(10):1207-18. PubMed ID: 10954054
[TBL] [Abstract][Full Text] [Related]
6. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.
Genne P; Dimanche-Boitrel MT; Mauvernay RY; Gutierrez G; Duchamp O; Petit JM; Martin F; Chauffert B
Cancer Res; 1992 May; 52(10):2797-801. PubMed ID: 1581892
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of anthracycline resistance by reserpine in P388 leukemia cells].
Shibata H; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):1-6. PubMed ID: 1889760
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of 1-methyl-3-propyl-7-butylxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia.
Sadzuka Y; Sugiyama T; Sawanishi H; Miyamoto K
Cancer Lett; 1999 Apr; 138(1-2):5-11. PubMed ID: 10378767
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
Ramachandran C; You W; Krishan A
Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
[TBL] [Abstract][Full Text] [Related]
10. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
[TBL] [Abstract][Full Text] [Related]
11. Cinchonine per os: efficient circumvention of P-glycoprotein-mediated multidrug resistance.
Genne P; Duchamp O; Solary E; Magnette J; Belon JP; Chauffert B
Anticancer Drug Des; 1995 Mar; 10(2):103-18. PubMed ID: 7710633
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine.
Viladkar A; Chitnis M
Cancer Biother; 1993; 8(1):77-85. PubMed ID: 7812352
[TBL] [Abstract][Full Text] [Related]
13. Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells.
Sadzuka Y; Egawa Y; Sawanishi H; Miyamoto K; Sonobe T
Toxicol Lett; 2002 Sep; 135(1-2):137-44. PubMed ID: 12243872
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
15. [Assay of flow cytometry for the effect of cepharanthine on resistance to doxorubicin].
Kisara S; Hayashi A; Maekawa I; Furusawa S; Takayanagi Y; Sasaki K
Yakugaku Zasshi; 1992 Nov; 112(11):837-45. PubMed ID: 1484349
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
[TBL] [Abstract][Full Text] [Related]
17. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of pirarubicin activity in multidrug resistant cells by rifampicin.
Furusawa S; Nakano S; Wu J; Sasaki K; Takayanagi M; Takayanagi Y
Biol Pharm Bull; 1997 Dec; 20(12):1303-6. PubMed ID: 9448109
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
